Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
55%
Threshold
Crossed downwards
Timeline
Published
18.03.2022
Transaction
14.03.2022
Voting rights breakdown
Voting rights acquired29.49%
Voting rights sold55%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAM3H00031
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
Acquisition and disposal of shares on March 14, 2022; also regarding certain sale positions.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open